5 results
Heparin, Fondaparinux, and Novel Oral Anticoagulants - Pathophysiology

Anticoagulation with parenteral (intravenous or subcutaneous) and oral anticoagulants
, LMWH, or fondaparinux ... #Heparins #LMWH ... #UFH #DOAC #Dabigatran ... #Apixaban #Rivaroxaban ... NOAC #Mechanism
Summary table of the mechanism of action, side effect and contraindications of commonly used anti-coagulation drugs.
Molecular Weight Heparin ... (LMWH) - Enoxaparin ... , rivaroxaban - ... #doac #comparison ... #table #management
Patient risk stratification algorithm for the treatment of cancer-associated thrombosis.

Currently, edoxaban and rivaroxaban are the only
, edoxaban and rivaroxaban ... filtration rate; DOAC ... anticoagulant; LMWH ... #DOAC #VTE #Malignancy ... #Management #Hematology
Heparin Induced Thrombocytopenia (HIT) - Diagnosis and Management - GrepMed Handbook

Presentation: 
 • Plts ↓50% (nadir
venous (DVT/PE) or arterial ... ♀, ↑Age, ESRD Pathophysiology ... : Argatroban, Fondaparinux ... , Bivalirudin, DOAC ... #Hematology #HemeOnc
Atrial Fibrillation (A-Fib) Summary

Symptoms:
• Palpitations, light-headedness, dizziness, dyspnea, exercise intolerance, chest pain, near-syncope, syncope.

Why?
Cardiac:
	• Valvular heart
: • Initial heparin ... typically needed • DOACs ... Xa inhibitors (rivaroxaban ... , apixaban, edoxaban ... #management #cardiology